visit
One of the biggest discoveries in the last century was figuring out how living organisms create these complex molecules. We eventually figured out how to engineer this process, particularly in microorganisms, like the bacteria E. coli. This allowed us to make it produce life-saving complex molecules like insulin.
I have two uncles who need to inject themselves with synthesized insulin. I'm sure you also know of people whose lives depend on insulin. Today, approximately 100 million people around the world need insulin. Producing insulin at this scale is a result of synthetic biology.If you are in IT, you'd know about Unix and its open-source counterpart, Linux. You'd probably also know that over 90% of the world's top 1 million web servers run on Linux. If you are an open-source aficionado, you'd know about Red Hat, a competitor to the likes of HP, IBM, and Oracle that built a huge services business supporting open source instead of proprietary software.If you are in the field of synthetic biology, or "synbio", you could probably give examples of synbio counterparts of Unix, and of companies like HP and IBM. However, you'll probably be hard-pressed at giving examples of their open-source equivalents in the synbio world. That's because we're still in synbio's pre-open-source phase.Let's look at previous open-source revolutions to see what might be needed to create open-source synthetic biology.An open community collaboratively creating a resource free for the world's use
I was a Wikipedia contributor back in 2005 - 2010. I was a combatant in a number of edit wars. I sometimes still visit talk pages to see the story behind a Wikipedia article. Alliances, rivalries, and even friendships were formed in those talk pages.Whatever our viewpoint on a topic was, we were united by a common goal and a common culture. We wanted well-written articles on topics we cared about. And we tried to abide by the principles of writing from a neutral point of view and assuming the good faith of fellow contributors.Open-source software projects are also fueled by open communities with a common goal and rules of engagement.A legal framework that protects the freedom of that community's creations
You'd want the law to be your ally if you want it to protect, or at least to not attack, the goods your community creates.Copyright law was originally intended to protect creators from copycats. Book authors and software developers also need to feed their kids. The law was intended to make sure they are paid for their work.What if your kids are already taken care of, and you just want to give away your work? This was a novel situation in the past decades. GNU GPL, Copyleft and Creative Commons were solutions within copyright law that protected not the income of creators, but the freedom of their creations.Broad access to equipment to contribute to creating that free resource
Prior to the internet, the ability to contribute to projects like Wikipedia or open-source software like Linux was limited to academics in rich countries. Because of the lowering cost of computation, hardware, and software, those of us in the periphery can now contribute to these projects.To see the parallels between software and synbio, let's first look at an example of a company built on proprietary synthetic biology, the counterpart of 80s' HP and IBM. is one of the unicorns in the synbio world. They engineer microorganisms for your business, so you could produce valuable molecules. For instance, Ginkgo is engineering E. coli for Cronos Group, a cannabis company, to produce cannabinoids without plants.
Their technology is proprietary, so it is a secret. But we know that they certainly have a wetware stack, a hardware stack, and a software stack.In synbio, "wetware" is the biological materials that you use for genetic engineering and fabrication, like engineered organisms and chemical reagents. Hardware is the machines that enable the same processes, like liquid handlers and bioreactors. And software are applications that help design these organisms and run the hardware. The collection of these stacks is called a biofoundry.Open-source software helped democratize access to computing. Similarly, an open-source biofoundry will democratize access to synthetic biology. I'm optimistic. We could already see in synbio the three ingredients that we saw in Wikipedia and in open-source software.First, an active, collaborative community has formed around synbio to develop and share ideas, resources, and technologies. For instance, the annual and global genetic engineering student competition, , has been seeding the open-source synthetic biology community for years. looks like the synbio counterpart of Y Combinator companies. For example, iGEM alumni are behind Ginkgo Bioworks as well as Just One Giant Lab, the open science platform that funded Project Accessible Genomics.Second, legal frameworks analogous to GNU GPL and Copyleft have been created for wetware. For instance, wetware under can be legally used both by academic institutions and by third-world entrepreneurs like me who want to produce reagents locally, to lower their costs and bypass rent-seeking or corrupt gate-keepers. Organizations like are using open source to solve the insulin pricing problem in the US. , , and are examples of organizations that distribute or promote free wetware.Finally, we are seeing in synbio a parallel to the evolution from expensive mainframes to personal computers that democratized contributing to open-source software. For instance, Project Accessible Genomics was only possible because of nanopore sequencing. Just a few years ago, a sequencer would cost more than a car. Today, you can get a MinION sequencer for less than the price of an iPhone. Opentrons has dropped the price of automated pipetting. Bentolab and miniPCR have done the same for core molecular biology lab equipment. (Opentrons and Bentolab are also built by iGEM alumni.)We are headed in the right direction, but there is still a lot of work to be done.Thanks to Sam Bhagwat and Dr. Nicole Wheeler for reading and giving feedback on early versions of this article.